ImmBio Company
Innovative vaccines. ImmBio is developing next-generation vaccines against serious infectious disease targets, utilising its proprietary technology platforms to directly induce immunity via dendritic cells.
Technology:
AgeTech Companies
Industry:
Covid-19
Headquarters:
United Kingdom
Register and Claim Ownership